UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000018497
Receipt number R000021402
Scientific Title Prospective study of I-131 3-iodobenzylguanidine radiotherapy for refractory pheochromocytoma; in accordance with the Japanese Advanced Medical Care B program for the anticancer drug with high medical needs.
Date of disclosure of the study information 2015/07/31
Last modified on 2020/02/13 13:47:16

No. Disposal Last modified on Item of update
1 Insert 2015/07/30 19:22:13
2 Update 2015/07/31 13:06:55 UMIN ID1
3 Update 2015/08/04 12:44:41 UMIN ID2
4 Update 2015/08/04 14:18:23 Interventions/Control_1
Interventions/Control_1
Key inclusion criteria
5 Update 2015/08/07 11:30:09 Interventions/Control_1
6 Update 2015/08/25 13:56:16 Public title
Public title
Acronym
Acronym
7 Update 2015/08/25 13:59:09 Condition
Narrative objectives1
Narrative objectives1
8 Update 2015/08/25 14:10:53 Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
9 Update 2015/08/25 14:14:01 Condition
10 Update 2015/12/07 21:11:02 Anticipated trial start date
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
11 Update 2016/02/15 18:23:08 Recruitment status
12 Update 2016/04/03 20:40:36 Name of primary person or sponsor
Institute
Organization
Organization
Institutions
13 Update 2016/06/04 18:03:56 Institutions
14 Update 2017/03/29 16:39:04 Name of person sending information
Name of person sending information
Organization
Organization
Division name
Division name
Email
15 Update 2018/07/23 07:31:23 Recruitment status
16 Update 2019/04/24 17:48:39 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
17 Update 2019/04/24 17:50:09 Date of IRB
18 Update 2019/05/20 14:56:06 Recruitment status
Other related information
19 Update 2020/02/13 12:41:26 URL releasing protocol
Publication of results
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Date of the first journal publication of results
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures
20 Update 2020/02/13 13:47:16 Recruitment status